[go: up one dir, main page]

WO1999024574A2 - Homologues vegetaux de pad1 et de crm1 de levure et de jab1 humaine: regulateurs de l'activite du facteur de transcription de type ap-1 - Google Patents

Homologues vegetaux de pad1 et de crm1 de levure et de jab1 humaine: regulateurs de l'activite du facteur de transcription de type ap-1 Download PDF

Info

Publication number
WO1999024574A2
WO1999024574A2 PCT/US1998/023487 US9823487W WO9924574A2 WO 1999024574 A2 WO1999024574 A2 WO 1999024574A2 US 9823487 W US9823487 W US 9823487W WO 9924574 A2 WO9924574 A2 WO 9924574A2
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
seq
acid fragment
amino acid
encoding
Prior art date
Application number
PCT/US1998/023487
Other languages
English (en)
Other versions
WO1999024574A3 (fr
Inventor
Stephen M. Allen
Shawn L. Anderson
William D. Hitz
Anthony J. Kinney
Guo-Hua Miao
Michele Morgante
Joan T. Odell
Hajime Sakai
Original Assignee
E.I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E.I. Du Pont De Nemours And Company filed Critical E.I. Du Pont De Nemours And Company
Priority to BR9815305-6A priority Critical patent/BR9815305A/pt
Priority to EP98957575A priority patent/EP1034274A2/fr
Priority to AU13804/99A priority patent/AU1380499A/en
Publication of WO1999024574A2 publication Critical patent/WO1999024574A2/fr
Publication of WO1999024574A3 publication Critical patent/WO1999024574A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology

Definitions

  • This invention is in the field of plant molecular More specifically, this invention pertains to nucleic acid fragments encoding proteins involved in the regulation of AP-1 transcription factor activity in plants and seeds.
  • the human jabl gene encodes a coactivater of the transcription factors c-Jun and JunD (Claret et al ( 1996) Nature 383 453-457)
  • the Schizosaccharomvccs pombe (fission ⁇ east) pad 1 gene encodes a coactivator of the Pap l transcription factor (Shimanuki et al (1995) J of Cell Science 108:569-519)
  • the S pombe crml gene encodes a negative regulator of the Papl transcription factor
  • the human Jab 1 protein enhances c-Jun activation of gene expression in mammalian cells
  • the human Jabl protein also enhances the binding of c-Jun to its target site in DNA, the TPA-Response Element, which is a type of AP- 1 site (Claret et al ( 1996) hature 553:453-457)
  • AP-1 sites are targets of the AP-1 regulatory proteins, which are dimers of Jun and Fos transcription factors
  • Human Jabl has 23% overall am o acid identity with Padl .
  • the protein coactivator encoded by pad 7. and 57% identity in the amino terminus of this protem Human Jabl has some properties of the S pombe coactivator Pad l
  • Yeast Padl enhances Pap l activation of gene expression Like c-Jun, Pap l is an AP-1 type of transcription factor
  • the pad 7 gene product is also required for the maintenance of higher-order chromatin structure and is an essential gene of 5 pombe (Shimanuki et al (1995) J of Cell Science 108:569-519) Overexpression of padl confers pleiotropic drug resistance, including resistance to staurosporme. cvclohexamide. thiabendazole. vanadate.
  • the S pombe and S DC evisiae crml gene encodes a negative regulator of Pap l crml mutants have an elevated level of Pap l -dependent transcription, resistance to caffeine and staurosporme. and an abnormal chromosome structure (Kumada et al ( 1996) Mol Gen Genet 250 59-68 ) crml is an essential gene of veast
  • the gene product of a human homolog of crml is associated with the nuclear pore complex and is thought to be a soluble nuclear transport factor that interacts with the nuclear pore comlex (Fornerod et al. (1997) EMBOJ 7(5:807-816).
  • the instant invention relates to isolated nucleic acid fragments encoding proteins involved in the regulation of AP-1 transcription factor activity.
  • this invention concerns an isolated nucleic acid fragment encoding a plant homolog of Mus musculus.
  • Human or yeast Padl protein hereinafter "Padl”
  • Crml a plant homolog of a human or yeast Crml protein
  • Jabl a plant (other than rice) homolog of a human or rice Jabl protien
  • this invention relates to a nucleic acid fragment that is complementary to the nucleic acid fragment encoding a plant homolog of Padl, Crml or Jabl .
  • An additional embodiment of the instant invention pertains to a polypeptide encoding all or a substantial portion of a protein involved in the regulation of AP-1 transcription factor activity selected from the group consisting of Padl, Crml or Jabl .
  • the instant invention relates to a chimeric gene encoding a Padl. Crml or Jabl protein , or to a chimeric gene that comprises a nucleic acid fragment that is complementary to a nucleic acid fragment encoding a Padl, Crml or Jabl protein, operably linked to suitable regulatory sequences, wherein expression of the chimeric gene results in production of levels of the encoded protein in a transformed host cell that is altered (i.e., increased or decreased) from the level produced in an untransformed host cell.
  • the instant invention concerns a transformed host cell comprising in its genome a chimeric gene encoding a Padl, Crml or Jabl protein, operably linked to suitable regulatory sequences. Expression of the chimeric gene results in production of altered levels of the encoded protein in the transformed host cell.
  • the transformed host cell can be of eukaryotic or prokaryotic origin, and include cells derived from higher plants and microorganisms.
  • the invention also includes transformed plants that arise from transformed host cells of higher plants, and seeds derived from such transformed plants.
  • An additional embodiment of the instant invention concerns a method of altering the level of expression of a Padl, Crml or Jabl protein in a transformed host cell comprising: a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment encoding a Padl, Crml or Jabl protein; and b) growing the transformed host cell under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of altered levels of a Padl, Crml or Jabl protein in the transformed host cell.
  • An addition embodiment of the instant invention concerns a method for obtaining a nucleic acid fragment encoding all or a substantial portion of an amino acid sequence encoding a Padl, Crml or Jabl protein.
  • BRIEF DESCRIPTION OF THE DRAWINGS AND SEQUENCE DESCRIPTIONS The invention can be more fully understood from the following detailed description and the accompanying drawings and Sequence Listing which form a part of this application.
  • Figure 1 shows a comparison of the amino acid sequences of the yeast Padl protein having DDJB Accession No. D45047 (padl.
  • PRO the instant maize Padl protein homolog encoded by cDNA clone cc2.mn0001.gl 1 (Olgl Ipp.PRO), the instant soybean Padl protein homologs encoded by cDNA clone srl.pk0058.e3 (58e3pp.PRO), and the contig assembled from the sequences encoded by cDNA clones sfll.pk0012.fl2 and sre.pk0067.b8 (contigpp.PRO).
  • Figure 2 shows a comparison of the amino acid sequences of the yeast Crml protein having DDJB Accession No. D16355 (crml.PRO) and the instant maize (07hl Ipp.PRO) and soybean (68c7pp.PRO) Crml protein homologs encoded by cDNA clones cc71se- b.pk0007.hl 1 and srl.pk0068.c7, respectively.
  • Figure 3 shows a comparison of the amino acid sequences of the human (hjabl .PRO) and Arabidopsis thaliana (ajabl.PRO) Jabl proteins having GenBank Accession Nos. U65928 and AF000657.
  • SEQ ID NO:l is the nucleotide sequence of the entire cDNA insert in clone cc2.mn0001.gl 1 encoding a portion of the maize homolog of the yeast Padl protein.
  • SEQ ID NO:2 is the deduced amino acid sequence of a maize homolog of the yeast
  • SEQ ID NO: 3 is the nucleotide sequence of a contig assembled from the entire cDNA inserts in clones sfll.pk0012.fl2 and sre.pk0067.b8 encoding a portion of a soybean homolog of the yeast Padl protein.
  • SEQ ID NO:4 is the deduced partial amino acid sequence of a soybean homolog of the yeast Padl protein derived from the nucleotide sequence of SEQ ID NO:3.
  • SEQ ID NO: 5 is the nucleotide sequence of the entire cDNA insert in clone srl .pk0058.e3 encoding a portion of a soybean homolog of the yeast Padl protein.
  • SEQ ID NO:6 is the deduced partial amino acid sequence of a soybean homolog of the yeast Padl protein derived from the nucleotide sequence of SEQ ID NO:5.
  • SEQ ID NO: 7 is the nucleotide sequence of a portion of the cDNA insert in clone wlln.pk0036.c3 encoding a portion of a wheat homolog of the yeast Padl protein.
  • SEQ ID NO:8 is the deduced partial amino acid sequence of a wheat homolog of the yeast Padl protein derived from the nucleotide sequence of SEQ ID NO:7.
  • SEQ ID NO:9 is the nucleotide sequence of the entire cDNA insert in clone cc71se- b.pk0007.hl 1 encoding a portion of a maize homolog of the yeast Crml protein.
  • SEQ ID NO: 10 is the deduced partial amino acid sequence of a maize homolog of the yeast Crml protein derived from the nucleotide sequence of SEQ ID NO:9.
  • SEQ ID NO:l 1 is the nucleotide sequence comprising a portion of the cDNA insert in clone rlmln.pk002.dl9 encoding a portion of a rice homolog of a yeast Crml protein.
  • SEQ ID NO: 12 is the deduced partial amino acid sequence of a rice homolog of a yeast Crml protein derived from the nucleotide sequence of SEQ ID NO:l 1.
  • SEQ ID NO: 13 is the nucleotide sequence of the entire cDNA insert in clone srl.pk0068.c7 encoding a portion of a soybean homolog of the yeast Crml protein.
  • SEQ ID NO: 14 is the deduced partial amino acid sequence of a soybean homolog of the yeast Crml protein derived from the nucleotide sequence of SEQ ID NO: 13.
  • SEQ ID NO: 15 is the nucleotide sequence comprising a portion of the cDNA insert in clone srr3c.pk002.fl0 encoding a portion of a soybean homolog of a human Crml protein.
  • SEQ ID NO: 16 is the deduced partial amino acid sequence of a soybean homolog of a human Crml protein derived from the nucleotide sequence of SEQ ID NO:15.
  • SEQ ID NO: 17 is the nucleotide sequence comprising a portion of the cDNA insert in clone wreln.pk0047.b2 encoding a portion of a wheat homolog of a human Crml protein.
  • SEQ ID NO: 18 is the deduced partial amino acid sequence of a soybean homolog of a human Crml protein derived from the nucleotide sequence of SEQ ID NO:17.
  • SEQ ID NO: 19 is the nucleotide sequence of the entire cDNA insert in clone ceb3.pk0001.e5 encoding a portion of a maize homolog of the human Jabl protein.
  • SEQ ID NO:20 is the deduced amino acid sequence of a maize homolog of the human Jabl protein derived from the nucleotide sequence of SEQ ID NO: 19.
  • SEQ ID NO:21 is the nucleotide sequence comprising a portion of the cDNA insert in clone rcalc.pk005.il 4 encoding a portion of a rice homolog of a rice Jabl protein.
  • SEQ ID NO:22 is the deduced partial amino acid sequence of a rice Jabl protein derived from the nucleotide sequence of SEQ ID NO:21.
  • SEQ ID NO:23 is the nucleotide sequence of the entire cDNA insert in clone se2.pk0014.f4 encoding a portion of a soybean homolog of the human Jabl protein.
  • SEQ ID NO:24 is the deduced partial amino acid sequence of a soybean homolog of the human Jabl protein derived from the nucleotide sequence of SEQ ID NO:23.
  • SEQ ID NO:25 is the amino acid sequence encoding the yeast Padl protein having DDJB Accession No. D45047.
  • SEQ ID NO:26 is the amino acid sequence encoding the yeast Crml protein having
  • SEQ ID NO:27 is the amino acid sequence encoding the human Jabl protein having GenBank Accession No. U65928.
  • SEQ ID NO:28 is the amino acid sequence encoding the Arabidopsis thaliana Jabl protein having GenBank Accession No. AF000657.
  • the Sequence Listing contains the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUBMB standards described in Nucleic Acids Research 73:3021-3030 (1985) and in the Biochemical Journal 219 (No. 2,1:345-373 (1984) which are herein incorporated by reference.
  • the symbols and format used for nucleotide and amino acid sequence data comply with the rules set forth in 37 C.F.R. ⁇ 1.822.
  • an "isolated nucleic acid fragment” is a polymer of RNA or DNA that is single- or double- stranded, optionally containing synthetic, non-natural or altered nucleotide bases.
  • An isolated nucleic acid fragment in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA or synthetic DNA.
  • "contig” refers to an assemblage of overlapping nucleic acid sequences to form one contiguous nucleotide sequence. For example, several DNA sequences can be compared and aligned to identify common or overlapping regions. The individual sequences can then be assembled into a single contiguous nucleotide sequence.
  • substantially similar refers to nucleic acid fragments wherein changes in one or more nucleotide bases results in substitution of one or more amino acids, but do not affect the functional properties of the protein encoded by the DNA sequence. “Substantially similar” also refers to nucleic acid fragments wherein changes in one or more nucleotide bases does not affect the ability of the nucleic acid fragment to mediate alteration of gene expression by antisense or co-suppression technology.
  • Substantially similar also refers to modifications of the nucleic acid fragments of the instant invention such as deletion or insertion of one or more nucleotides that do not substantially affect the functional properties of the resulting transcript vis-a-vis the ability to mediate alteration of gene expression by antisense or co-suppression technology or alteration of the functional properties of the resulting protein molecule. It is therefore understood that the invention encompasses more than the specific exemplary sequences.
  • antisense suppression and co- suppression of gene expression may be accomplished using nucleic acid fragments representing less than the entire coding region of a gene, and by nucleic acid fragments that do not share 100% sequence identity with the gene to be suppressed.
  • alterations in a gene which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded protein are well known in the art.
  • a codon for the amino acid alanine, a hydrophobic amino acid may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine.
  • substantially similar nucleic acid sequences encompassed by this invention are also defined by their ability to hybridize, under stringent conditions (0.1X SSC, 0.1% SDS, 65°C), with the sequences exemplified herein.
  • Preferred substantially similar nucleic acid fragments of the instant invention are those nucleic acid fragments whose DNA sequences are 80%o identical to the coding sequence of the nucleic acid fragments reported herein. More preferred nucleic acid fragments are 90%> identical to the coding sequence of the nucleic acid fragments reported herein. Most preferred are nucleic acid fragments that are 95% identical to the coding sequence of the nucleic acid fragments reported herein.
  • a "substantial portion" of an amino acid or nucleotide sequence comprises enough of the amino acid sequence of a polypeptide or the nucleotide sequence of a gene to afford putative identification of that polypeptide or gene, either by manual evaluation of the sequence by one skilled in the art, or by computer-automated sequence comparison and identification using algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul, S. F., et al., (1993) J. Mol. Biol. 275:403-410; see also www.ncbi.nlm.nih.gov/BLAST/).
  • BLAST Basic Local Alignment Search Tool
  • a sequence often or more contiguous amino acids or thirty or more nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene.
  • gene specific oligonucleotide probes comprising 20-30 contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bactenophage plaques).
  • short oligonucleotides of 12-15 bases may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers.
  • a "substantial portion" of a nucleotide sequence comprises enough of the sequence to afford specific identification and/or isolation of a nucleic acid fragment comprising the sequence.
  • the instant specification teaches partial or complete amino acid and nucleotide sequences encoding one or more particular plant proteins. The skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above. "Codon degeneracy" refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide.
  • the instant invention relates to any nucleic acid fragment that encodes all or a substantial portion of the amino acid sequence encoding the Padl, Crml or Jabl proteins as set forth in SEQ ID NOs:2, 4, 6, 8, 10, 12. 14, 16, 18, 20, 22 and 24.
  • the skilled artisan is well aware of the "codon-bias" exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a gene for improved expression in a host cell, it is desirable to design the gene such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell.
  • “Synthetic genes” can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form gene segments which are then enzymatically assembled to construct the entire gene. "Chemically synthesized”, as related to a sequence of DNA, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of DNA may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the genes can be tailored for optimal gene expression based on optimization of nucleotide sequence to reflect the codon bias of the host cell.
  • Gene refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding sequences) and following (3' non-coding sequences) the coding sequence.
  • Native gene refers to a gene as found in nature with its own regulatory sequences.
  • Chimeric gene refers any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature.
  • a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature.
  • Endogenous gene refers to a native gene in its natural location in the genome of an organism.
  • a “foreign” gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer.
  • Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes.
  • a “transgene” is a gene that has been introduced into the genome by a transformation procedure.
  • Coding sequence refers to a DNA sequence that codes for a specific amino acid sequence.
  • Regulatory sequences refer to nucleotide sequences located upstream (5' non- coding sequences), within, or downstream (3' non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences.
  • Promoter refers to a DNA sequence capable of controlling the expression of a coding sequence or functional RNA.
  • a coding sequence is located 3' to a promoter sequence.
  • the promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers.
  • an “enhancer” is a DNA sequence which can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments.
  • promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as "constitutive promoters". New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by
  • the "translation leader sequence” refers to a DNA sequence located between the promoter sequence of a gene and the coding sequence.
  • the translation leader sequence is present in the fully processed mRNA upstream of the translation start sequence.
  • the translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner, R. and Foster, G.D. (1995) Molecular Biotechnology 3:225).
  • the "3' non-coding sequences” refer to DNA sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression.
  • the polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor.
  • the use of different 3' non-coding sequences is exemplified by Ingelbrecht et al., (1989) Plant Cell 7:671-680.
  • RNA transcript refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing of the primary transcript and is referred to as the mature RNA.
  • Messenger RNA (mRNA) refers to the RNA that is without introns and that can be translated into protein by the cell.
  • cDNA refers to a double-stranded DNA that is complementary to and derived from mRNA.
  • Sense RNA transcript that includes the mRNA and so can be translated into protein by the cell.
  • Antisense RNA refers to a RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (U.S. Pat. No. 5,107,065, incorporated herein by reference). The complementarity of an antisense RNA may be with any part of the specific gene transcript, i.e., at the 5' non-coding sequence, 3' non-coding sequence, introns, or the coding sequence.
  • “Functional RNA” refers to antisense RNA, ribozyme RNA, or other RNA that may not be translated but yet has an effect on cellular processes.
  • operably linked refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is affected by the other.
  • a promoter is operably linked with a coding sequence when it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter).
  • Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation.
  • expression refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide.
  • Antisense inhibition refers to the production of antisense RNA transcripts capable of suppressing the expression of the target protein.
  • Overexpression refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms.
  • Co-suppression refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Pat. No. 5,231,020, incorporated herein by reference).
  • altered levels refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non-transformed organisms.
  • “Mature” protein refers to a post-translationally processed polypeptide; i.e., one from which any pre- or propeptides present in the primary translation product have been removed.
  • Precursor protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and propeptides may be but are not limited to intracellular localization signals.
  • Transformation refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as "transgenic" organisms. Examples of methods of plant transformation include Agrobacterium-mediated transformation (De Blaere et al. (1987) Meth. Enzymol. 143:211) and particle-accelerated or “gene gun” transformation technology (Klein et al. (1987) Nature (London) 327:10-13; U.S. Pat. No. 4,945,050, incorporated herein by reference).
  • Nucleic acid fragments encoding at least a portion of several proteins involved in the regulation of AP-1 transcription factor activity have been isolated and identified by comparison of random plant cDN A sequences to public databases containing nucleotide and protein sequences using the BLAST algorithms well known to those skilled in the art.
  • Table 1 lists the proteins that are described herein, and the designation of the cDNA clones that comprise the nucleic acid fragments encoding these proteins.
  • the nucleic acid fragments of the instant invention may be used to isolate cDNAs and genes encoding homologous proteins from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridization, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g., polymerase chain reaction, ligase chain reaction).
  • genes encoding other Padl, Crml and Jabl proteins could be isolated directly by using all or a portion of the instant nucleic acid fragments as DNA hybridization probes to screen libraries from any desired plant employing methodology well known to those skilled in the art.
  • Specific oligonucleotide probes based upon the instant nucleic acid sequences can be designed and synthesized by methods known in the art (Maniatis).
  • the entire sequences can be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primer DNA labeling, nick translation, or end-labeling techniques, or RNA probes using available in vitro transcription systems.
  • primers can be designed and used to amplify a part or all of the instant sequences.
  • the resulting amplification products can be labeled directly during amplification reactions or labeled after amplification reactions, and used as probes to isolate full length cDNA or genomic fragments under conditions of appropriate stringency.
  • two short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols to amplify longer nucleic acid fragments encoding homologous genes from DNA or RNA.
  • the polymerase chain reaction may also be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the instant nucleic acid fragments, and the sequence of the other primer takes advantage of the presence of the polyadenylic acid tracts to the 3' end of the mRNA precursor encoding plant genes.
  • the second primer sequence may be based upon sequences derived from the cloning vector.
  • the skilled artisan can follow the RACE protocol (Frohman et al., (1988) PNAS USA 55:8998) to generate cDNAs by using PCR to amplify copies of the region between a single point in the transcript and the 3' or 5' end. Primers oriented in the 3' and 5' directions can be designed from the instant sequences. Using commercially available 3' RACE or 5' RACE systems (BRL), specific 3' or 5' cDNA fragments can be isolated (Ohara et al., (1989) PNAS USA 86:5613; Loh et al., (1989) Science 243:211). Products generated by the 3' and 5' RACE procedures can be combined to generate full-length cDNAs (Frohman, M.A. and Martin, G.R., (1989) Techniques 7: 165).
  • RACE protocol Frohman et al., (1988) PNAS USA 55:8998
  • Synthetic peptides representing portions of the instant amino acid sequences may be synthesized. These peptides can be used to immunize animals to produce polyclonal or monoclonal antibodies with specificity for peptides or proteins comprising the amino acid sequences. These antibodies can be then be used to screen cDNA expression libraries to isolate full-length cDNA clones of interest (Lerner, R. A. (1984) Adv. Immunol. 36:1; Maniatis).
  • the nucleic acid fragments of the instant invention may be used to create transgenic plants in which the disclosed Padl, Crml and Jabl proteins are present at higher or lower levels than normal or in cell types or developmental stages in which they are not normally found. This would have the effect of altering the level of AP-1 transcription factor activity in those cells.
  • Overexpression of the Padl. Crml and Jabl proteins of the instant invention may be accomplished by first constructing a chimeric gene in which the coding region is operably linked to a promoter capable of directing expression of a gene in the desired tissues at the desired stage of development.
  • the chimeric gene may comprise promoter sequences and translation leader sequences derived from the same genes.
  • 3' Non- coding sequences encoding transcription termination signals may also be provided.
  • the instant chimeric gene may also comprise one or more introns in order to facilitate gene expression.
  • Plasmid vectors comprising the instant chimeric gene can then constructed.
  • the choice of plasmid vector is dependent upon the method that will be used to transform host plants. The skilled artisan is well aware of the genetic elements that must be present on the plasmid vector in order to successfully transform, select and propagate host cells containing the chimeric gene. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al., (1985) EMBOJ. -7:2411-2418; De Almeida et al., (1989) Mol. Gen. Genetics 275:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accomplished by Southern analysis of DNA, Northern analysis of mRNA expression, Western analysis of protein expression, or phenotypic analysis. It may also be desirable to reduce or eliminate expression of genes encoding Padl ,
  • a chimeric gene designed for co-suppression of the instant proteins involved in the regulation of AP-1 transcription factor activity can be constructed by linking a gene or gene fragment encoding a Padl, Crml or Jabl protein to plant promoter sequences.
  • a chimeric gene designed to express antisense RNA for all or part of the instant nucleic acid fragment can be constructed by linking the gene or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense chimeric genes could be introduced into plants via transformation wherein expression of the corresponding endogenous genes are reduced or eliminated.
  • the instant Padl, Crml or Jabl protein may be produced in heterologous host cells, particularly in the cells of microbial hosts, and can be used to prepare antibodies to the these proteins by methods well known to those skilled in the art.
  • the antibodies are useful for detecting Padl, Crml or Jabl proteins in situ in cells or in vitro in cell extracts.
  • Preferred heterologous host cells for production of the instant Padl, Crml or Jabl proteins are microbial hosts.
  • Microbial expression systems and expression vectors containing regulatory sequences that direct high level expression of foreign proteins are well known to those skilled in the art. Any of these could be used to construct a chimeric gene for production of the instant Padl. Crml or Jabl proteins.
  • This chimeric gene could then be introduced into appropriate microorganisms via transformation to provide high level expression of the encoded proteins involved in the regulation of gene expression.
  • An example of a vector for high level expression of the instant Padl, Crml or Jabl proteins in a bacterial host is provided (Example 8).
  • nucleic acid fragments of the instant invention may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes.
  • the instant nucleic acid fragments may be used as restriction fragment length polymorphism (RFLP) markers.
  • RFLP restriction fragment length polymorphism
  • Southern blots (Maniatis) of restriction-digested plant genomic DNA may be probed with the nucleic acid fragments of the instant invention.
  • the resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et at., (1987) Genomics 7:174-181) in order to construct a genetic map.
  • nucleic acid fragments of the instant invention may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the instant nucleic acid sequence in the genetic map previously obtained using this population (Botstein. D. et al., (1980) Am. J. Hum. Genet. 32:314-331).
  • nucleic acid probes derived from the instant nucleic acid sequences may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel, J. D., et al., In: Nonmammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein).
  • nucleic acid probes derived from the instant nucleic acid sequences may be used in direct fluorescence in situ hybridization (FISH) mapping (Trask, B. J. (1991) Trends Genet. 7:149-154).
  • FISH direct fluorescence in situ hybridization
  • nucleic acid amplification-based methods of genetic and physical mapping may be carried out using the instant nucleic acid sequences. Examples include allele-specific amplification (Kazazian, H. H. (1989) J. Lab. Clin. Med. 114(2):95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield, V. C. et al. (1993) Genomics 7(5:325-332), allele-specific ligation (Landegren, U. et al. (1988) Science 247:1077-1080). nucleotide extension reactions (Sokolov, B. P. (1990) Nucleic Acid Res. 75:3671), Radiation Hybrid Mapping (Walter, M. A.
  • Loss of function mutant phenotypes may be identified for the instant cDNA clones either by targeted gene disruption protocols or by identifying specific mutants for these genes contained in a maize population carrying mutations in all possible genes (Ballinger and Benzer, (1989) Proc. Natl. Acad. Sci USA 86:9402; Koes et al., (1995) Proc. Natl. Acad. Sci USA 92:8149; Bensen et al., (1995) Plant Cell 7:15). The latter approach may be accomplished in two ways.
  • short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols in conjunction with a mutation tag sequence primer on DNAs prepared from a population of plants in which Mutator transposons or some other mutation-causing DNA element has been introduced (see Bensen, supra).
  • the amplification of a specific DNA fragment with these primers indicates the insertion of the mutation tag element in or near the plant gene encoding the Padl, Crml or Jabl protein.
  • the instant nucleic acid fragment may be used as a hybridization probe against PCR amplification products generated from the mutation population using the mutation tag sequence primer in conjunction with an arbitrary genomic site primer, such as that for a restriction enzyme site-anchored synthetic adaptor.
  • a plant containing a mutation in the endogenous gene encoding a Padl, Crml or Jabl protein can be identified and obtained. This mutant plant can then be used to determine or confirm the natural function of the Padl, Crml or Jabl protein gene product.
  • EXAMPLES The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof can make various changes and modifications of the invention to adapt it to various usages and conditions.
  • EXAMPLE 1 Composition of cDNA Libraries; Isolation and Sequencing of cDNA Clones cDNA libraries representing mRNAs from various corn, rice, soybean and wheat tissues were prepared. The characteristics of the libraries are described below.
  • cDNA libraries were prepared in Uni-ZAPTM XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems. La Jolla, CA). Conversion of the Uni-ZAPTM XR libraries into plasmid libraries was accomplished according to the protocol provided by Stratagene. Upon conversion, cDNA inserts were contained in the plasmid vector pBluescript. cDNA inserts from randomly picked bacterial colonies containing recombinant pBluescript plasmids were amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences or plasmid DNA was prepared from cultured bacterial cells.
  • the sequence of the entire cDNA insert in clone cc2.mn0001.gl 1 was determined and is shown in SEQ ID NO:l ; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:2.
  • the amino acid sequence set forth in SEQ ID NO:2 was evaluated by BLASTX, yielding a pLog value of 136.70 versus theyeast sequence.
  • sequences of the entire cDNA inserts in clones sre.pk0067.b8 and sfll.pk0012.fl2 were determined. In the process of comparing the entrire cDNA sequences it was found that clones sre.pk0067.b8 and sfll.pk0012.fl2 had overlapping regions of homology. Using this homology it was possible to align the cDNA sequences and assemble a contig (a contig is an assemblage of overlapping nucleic acid sequences to form one contiguous nucleotide sequence).
  • the individual sequences were assembled into a contiguous nucleotide sequence encoding a unique soybean Padl protein and is shown in SEQ ID NO:3; the deduced amino acid sequence of this cDNA contig is shown in SEQ ID NO:4.
  • the amino acid sequence set forth in SEQ ID NO:4 was evaluated by BLASTX, yielding a pLog value of 134.57 versus the yeast sequence.
  • the sequence of the entire cDNA insert in clone srl .pk0058.e3 was determined and is shown in SEQ ID NO:5; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:6.
  • the soybean peptide encoded by this clone is approximately 97% identical to soybean Padl encoded by cDNA clone sre.pk0067.b8.
  • Table 4 represents a calculation of the percent identity of the amino acid sequences set forth in SEQ ID NOs:2, 4 and 6 and the yeast Padl sequence.
  • SEQ ID NO:7 the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:8.
  • BLAST scores and probabilities indicate that the instant nucleic acid fragment encodes a portion of Padl polypeptide. This sequence represents the first wheat sequence encoding Padl . Sequence alignments and BLAST scores and probabilities indicate that the instant nucleic acid fragments encode entire or nearly entire Padl polypeptids. These sequences represent the first corn, soybean and wheat sequences encoding a Padl protein.
  • the amino acid sequence set forth in SEQ ID NO: 10 was evaluated by BLASTX, yielding a pLog value of 109.92 versus the yeast sequence.
  • the sequence of a portion of the cDNA insert from clone rlmln.pk002.dl9 is shown in SEQ ID NO: 11 ; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO: 12.
  • the sequence of the entire cDNA insert in clone srl .pk0068.c7 was determined and is shown in SEQ ID NO: 13; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO: 14.
  • the amino acid sequence set forth in SEQ ID NO: 14 was evaluated by BLASTX, yielding a pLog value of 160.42 versus the yeast sequence.
  • the sequence of a portion of the cDNA insert from clone srr3c.pk002.fl0 is shown in SEQ ID NO: 15; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:16.
  • the sequence of a portion of the cDNA insert from clone wasln.pk0047.b2 is shown in SEQ ID NO: 17; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO: 18.
  • Figure 2 presents an alignment of the amino acid sequences set forth in SEQ ID NO:
  • Table 7 represents a calculation of the percent identity of the amino acid sequences set forth in SEQ ID NOs: 10 and 14 and the yeast sequence.
  • sequence of the entire cDNA insert in clone ceb3.pk0001.e5 was determined and is shown in SEQ ID NO: 19; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:20.
  • the amino acid sequence set forth in SEQ ID NO:20 was evaluated by
  • SEQ ID NO:21 the deduced amino acid sequence of this clone is shown in SEQ ID NO:22.
  • BLAST scores and probabilities indicate that the instant nucleic acid fragment encodes a portion of a rice Jabl polypeptide.
  • the sequence of the entire cDNA insert in clone se2.pk0014.f4 was determined and is shown in SEQ ID NO:23; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:24.
  • the amino acid sequence set forth in SEQ ID NO:24 was evaluated by BLASTX, yielding a pLog value of 157.54 versus the human sequence and a pLog value of 197.55 versus mi Arabidopsis thaliana sequence believed to be similar to the Jun Activation Binding Domain protein (GenBank Accession No. AF000657), thus confirming the identity of the sequence encoded by this clone.
  • Figure 3 presents an alignment of the amino acid sequences set forth in SEQ ID NOs:20 and 24 and the human and Arabidopsis thaliana sequences.
  • the data in Table 9 represents a calculation of the percent identity of the amino acid sequences set forth in SEQ ID NOs:20 and 24 and the human and Arabidopsis thaliana sequences. TABLE 9
  • a chimeric gene comprising a cDNA encoding a protein involved in the regulation of AP-1 transcription factor activityin sense orientation with respect to the maize 27 kD zein promoter that is located 5' to the cDNA fragment, and the 10 kD zein 3' end that is located 3' to the cDNA fragment, can be constructed.
  • the cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites (Ncol or Smal) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pML103 as described below.
  • Plasmid pML103 has been deposited under the terms of the Budapest Treaty at ATCC (American Type Culture Collection, 10801 University Boulevard., Manassas, VA 20110-2209), and bears accession number ATCC 97366.
  • the DNA segment from pML103 contains a 1.05 kb Sall-Ncol promoter fragment of the maize 27 kD zein gene and a 0.96 kb Smal-Sall fragment from the 3' end of the maize 10 kD zein gene in the vector pGem9Zf(+) (Promega).
  • Vector and insert DNA can be ligated at 15°C overnight, essentially as described (Maniatis). The ligated DNA may then be used to transform E. coli XLl-Blue (Epicurian Coli XL-1 BlueTM; Stratagene).
  • Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method (SequenaseTM DNA Sequencing Kit; U. S. Biochemical).
  • the resulting plasmid construct would comprise a chimeric gene encoding, in the 5' to 3' direction, the maize 27 kD zein promoter, a cDNA fragment encoding a protein involved in the regulation of gene expression, and the 10 kD zein 3' region.
  • the chimeric gene described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses of the inbred corn lines H99 and LH132.
  • the embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long.
  • the embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al., (1975) Sci. Sin. Peking 18:659-668).
  • the embryos are kept in the dark at 27°C.
  • Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoids borne on suspensor structures proliferates from the scutellum of these immature embryos.
  • the embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks.
  • the plasmid, p35S/Ac obtained from Dr. Peter Eckes. Hoechst Ag, Frankfurt,
  • This plasmid contains the Pat gene (see European Patent Publication 0 242 236) which encodes phosphinothricin acetyl transferase (PAT).
  • PAT phosphinothricin acetyl transferase
  • the enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin.
  • the pat gene in p35S/Ac is under the control of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812) and the 3' region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.
  • the particle bombardment method (Klein et al., (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells.
  • gold particles (1 ⁇ m in diameter) are coated with DNA using the following technique.
  • Ten ⁇ g of plasmid DNAs are added to 50 ⁇ L of a suspension of gold particles (60 mg per mL).
  • Calcium chloride 50 ⁇ L of a 2.5 M solution
  • spermidine free base (20 ⁇ L of a 1.0 M solution) are added to the particles.
  • the suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed.
  • the particles are resuspended in 200 ⁇ L of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 ⁇ L of ethanol.
  • An aliquot (5 ⁇ L) of the DNA-coated gold particles can be placed in the center of a KaptonTM flying disc (Bio-Rad Labs).
  • the particles are then accelerated into the corn tissue with a BiolisticTM PDS-1000/He (Bio-Rad Instruments, Hercules CA), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm.
  • the embryogenic tissue is placed on filter paper over agarose- solidified N6 medium.
  • the tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter.
  • the petri dish containing the tissue can be placed in the chamber of the PDS-1000/He approximately 8 cm from the stopping screen.
  • the air in the chamber is then evacuated to a vacuum of 28 inches of Hg.
  • the macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi.
  • Seven days after bombardment the tissue can be transferred to N6 medium that contains gluphosinate (2 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium.
  • tissue can be transferred to fresh N6 medium containing gluphosinate. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some of the plates containing the glufosinate- supplemented medium. These calli may continue to grow when sub-cultured on the selective medium.
  • Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al., (1990) Bio/Technology 5:833-839).
  • a seed-specific expression cassette composed of the promoter and transcription terminator from the gene encoding the ⁇ subunit of the seed storage protein phaseolin from the bean Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem. 26 ⁇ :9228-9238) can be used for expression of the instant proteins involved in regulation of AP-1 transcription factor activityin transformed soybean.
  • the phaseolin cassette includes about 500 nucleotides upstream (5') from the translation initiation codon and about 1650 nucleotides downstream (3') from the translation stop codon of phaseolin.
  • Nco I which includes the ATG translation initiation codon
  • Sma I which includes the ATG translation initiation codon
  • Kpn I The entire cassette is flanked by Hind III sites.
  • the cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the expression vector. Amplification is then performed as described above, and the isolated fragment is inserted into a pUC18 vector carrying the seed expression cassette.
  • PCR polymerase chain reaction
  • Soybean embroys may then be transformed with the expression vector comprising sequences encoding proteins involved in the regulation of gene expression.
  • somatic embryos cotyledons, 3-5 mm in length dissected from surface sterilized, immature seeds of the soybean cultivar A2872, can be cultured in the light or dark at 26°C on an appropriate agar medium for 6-10 weeks. Somatic embryos which produce secondary embryos are then excised and placed into a suitable liquid medium. After repeated selection for clusters of somatic embryos which multiplied as early, globular staged embryos, the suspensions are maintained as described below.
  • Soybean embryogenic suspension cultures can maintained in 35 mL liquid media on a rotary shaker, 150 rpm, at 26°C with florescent lights on a 16:8 hour day /night schedule. Cultures are subcultured every two weeks by inoculating approximately 35 mg of tissue into 35 mL of liquid medium.
  • Soybean embryogenic suspension cultures may then be transformed by the method of particle gun bombardment (Kline et al. (1987) Nature (London) 327:70, U.S. Patent No. 4,945,050).
  • a Du Pont BiolisticTM PDS1000/HE instrument helium retrofit
  • a selectable marker gene which can be used to facilitate soybean transformation is a chimeric gene composed of the 35S promoter from Cauliflower Mosaic Virus (Odell et al.(1985) Nature 373:810-812), the hygromycin phosphotransferase gene from plasmid pJR225 (from E. coli; Gritz et al.(1983) Gene 25:179-188) and the 3' region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.
  • the seed expression cassette comprising the phaseolin 5' region, the fragment encoding the protein involved in the regulation of AP-1 transcription factor activityand the phaseolin 3' region can be isolated as a restriction fragment. This fragment can then be inserted into a unique restriction site of the vector carrying the marker gene.
  • 50 ⁇ L of a 60 mg/mL 1 ⁇ m gold particle suspension is added (in order): 5 ⁇ L
  • DNA (1 ⁇ g/ ⁇ L), 20 ⁇ l spermidine (0.1 M), and 50 ⁇ L CaCl 2 (2.5 M).
  • the particle preparation is then agitated for three minutes, spun in a micro fuge for 10 seconds and the supernatant removed.
  • the DNA-coated particles are then washed once in 400 ⁇ L 70%> ethanol and resuspended in 40 ⁇ L of anhydrous ethanol.
  • the DNA/particle suspension can be sonicated three times for one second each. Five ⁇ L of the DNA-coated gold particles are then loaded on each macro carrier disk.
  • Approximately 300-400 mg of a two-week-old suspension culture is placed in an empty 60x15 mm petri dish and the residual liquid removed from the tissue with a pipette.
  • approximately 5-10 plates of tissue are normally bombarded.
  • Membrane rupture pressure is set at 1100 psi and the chamber is evacuated to a vacuum of 28 inches mercury.
  • the tissue is placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue can be divided in half and placed back into liquid and cultured as described above.
  • the liquid media may be exchanged with fresh media, and eleven to twelve days post bombardment with fresh media containing 50 mg/mL hygromycin. This selective media can be refreshed weekly.
  • green, transformed tissue may be observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue is removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Each new line may be treated as an independent transformation event. These suspensions can then be subcultured and maintained as clusters of immature embryos or regenerated into whole plants by maturation and germination of individual somatic embryos.
  • the cDN As encoding the instant proteins involved in the regulation of AP- 1 transcription factor activity can be inserted into the T7 E. coli expression vector pBT430.
  • This vector is a derivative of pET-3a (Rosenberg et al. (1987) Gene 5(5:125-135) which employs the bacteriophage T7 RNA polymerase/T7 promoter system.
  • Plasmid pBT430 was constructed by first destroying the EcoR I and Hind III sites in pET-3a at their original positions. An oligonucleotide adaptor containing EcoR I and Hind III sites was inserted at the BamH I site of pET-3a.
  • Plasmid DNA containing a cDNA may be appropriately digested to release a nucleic acid fragment encoding the protein. This fragment may then be purified on a 1% NuSieve GTGTM low melting agarose gel (FMC). Buffer and agarose contain 10 ⁇ g/ml ethidium bromide for visualization of the DNA fragment. The fragment can then be purified from the agarose gel by digestion with GELaseTM (Epicentre Technologies) according to the manufacturer's instructions, ethanol precipitated, dried and resuspended in 20 ⁇ L of water. Appropriate oligonucleotide adapters may be ligated to the fragment using T4 DNA ligase (New England Biolabs, Beverly, MA).
  • the fragment containing the ligated adapters can be purified from the excess adapters using low melting agarose as described above.
  • the vector pBT430 is digested, dephosphorylated with alkaline phosphatase (NEB) and deproteinized with phenol/chloroform as decribed above.
  • the prepared vector pBT430 and fragment can then be ligated at 16°C for 15 hours followed by transformation into DH5 electrocompetent cells (GIBCO BRL).
  • Transformants can be selected on agar plates containing LB media and 100 ⁇ g/mL ampicillin.
  • Transformants containing the gene encoding the proteins involved in the regulation of AP-1 transcription factor activity are then screened for the correct orientation with respect to the T7 promoter by restriction enzyme analysis.
  • a plasmid clone with the cDNA insert in the correct orientation relative to the T7 promoter can be transformed into E. coli strain BL21(D ⁇ 3) (Studier et al. (1986) J. Mol. Biol. 759:1 13-130). Cultures are grown in LB medium containing ampicillin (100 mg/L) at 25°C. At an optical density at 600 nm of approximately 1 , IPTG (isopropylthio- ⁇ -galactoside, the inducer) can be added to a final concentration of 0.4 mM and incubation can be continued for 3 h at 25°.
  • IPTG isopropylthio- ⁇ -galactoside, the inducer
  • Cells are then harvested by centrifugation and re-suspended in 50 ⁇ L of 50 mM Tris-HCl at pH 8.0 containing 0.1 mM DTT and 0.2 mM phenyl methylsulfonyl fluoride.
  • a small amount of 1 mm glass beads can be added and the mixture sonicated 3 times for about 5 seconds each time with a microprobe sonicator.
  • the mixture is centrifuged and the protein concentration of the supernatant determined.
  • One ⁇ g of protein from the soluble fraction of the culture can be separated by SDS-polyacrylamide gel electrophoresis. Gels can be observed for protein bands migrating at the expected molecular weight.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne un fragment d'acide nucléique codant pour une protéine impliquée dans la régulation de l'activité du facteur de transcription AP-1. Elle concerne également la construction d'un gène chimère codant pour tout ou partie de ladite protéine, en orientation sens ou antisens, dont l'expression modifie le niveau de la protéine impliquée dans l'activité du facteur de transcription AP-1 dans une cellule hôte transformée.
PCT/US1998/023487 1997-11-07 1998-11-04 Homologues vegetaux de pad1 et de crm1 de levure et de jab1 humaine: regulateurs de l'activite du facteur de transcription de type ap-1 WO1999024574A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BR9815305-6A BR9815305A (pt) 1997-11-07 1998-11-04 Fragmento de acido nucléico, gene quimérico, célula hospedeira, polipeptidio pad1, polipeptìdio jab1, método para a alteração do nìvel de expressão de uma proteìna, método para obtenção de um fragmento de ácido nucléico e produto
EP98957575A EP1034274A2 (fr) 1997-11-07 1998-11-04 Homologues vegetaux de pad1 et de crm1 de levure et de jab1 humaine: regulateurs de l'activite du facteur de transcription de type ap-1
AU13804/99A AU1380499A (en) 1997-11-07 1998-11-04 Plant homologs of yeast pad1, yeast crm1, and human jab1: regulators of ap-1 type transcription factor activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6491497P 1997-11-07 1997-11-07
US60/064,914 1997-11-07

Publications (2)

Publication Number Publication Date
WO1999024574A2 true WO1999024574A2 (fr) 1999-05-20
WO1999024574A3 WO1999024574A3 (fr) 1999-12-09

Family

ID=22059097

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/023487 WO1999024574A2 (fr) 1997-11-07 1998-11-04 Homologues vegetaux de pad1 et de crm1 de levure et de jab1 humaine: regulateurs de l'activite du facteur de transcription de type ap-1

Country Status (4)

Country Link
EP (1) EP1034274A2 (fr)
AU (1) AU1380499A (fr)
BR (1) BR9815305A (fr)
WO (1) WO1999024574A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29916160U1 (de) 1999-09-14 2000-03-09 Cardiogene Gentherapeutische Systeme AG, 40699 Erkrath Modulation der Transkription von Genen in vaskulären Zellen
FR2806095A1 (fr) * 2000-03-10 2001-09-14 Gentech Sequences polynucleotidiques purifiees de plantes et de levure codant pour des proteines qui interagissent avec les produits du genome des geminivirus
WO2001038566A3 (fr) * 1999-11-26 2001-11-29 Fraunhofer Ges Forschung Procede de criblage pour medicaments candidats
US6599741B1 (en) 1999-09-14 2003-07-29 Avontec Gmbh Modulating transcription of genes in vascular cells
KR100602146B1 (ko) 2004-08-31 2006-07-19 학교법인 성균관대학 Ｊａｂ1을 포함하는 바이러스 감염 질환 치료 조성물
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005249A2 (fr) * 1995-07-31 1997-02-13 The Government Of The United States Of America, Represented By The Secretary, Department Of Healt H And Human Services Prolongement d'une surface d'interaction proteine-proteine afin d'inactiver le fonctionnement d'une proteine cellulaire

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
DE29916160U1 (de) 1999-09-14 2000-03-09 Cardiogene Gentherapeutische Systeme AG, 40699 Erkrath Modulation der Transkription von Genen in vaskulären Zellen
US6599741B1 (en) 1999-09-14 2003-07-29 Avontec Gmbh Modulating transcription of genes in vascular cells
US7186556B2 (en) 1999-09-14 2007-03-06 Avontec Gmbh Modulating transcription of genes in vascular cells
WO2001038566A3 (fr) * 1999-11-26 2001-11-29 Fraunhofer Ges Forschung Procede de criblage pour medicaments candidats
US7303885B1 (en) 1999-11-26 2007-12-04 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Screening method for candidate drugs
EP1990413A1 (fr) * 1999-11-26 2008-11-12 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Procédé de criblage pour médicaments candidats
EP2033972A1 (fr) * 1999-11-26 2009-03-11 Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. Procédé de criblage pour médicaments candidats
USRE43497E1 (en) 1999-11-26 2012-06-26 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Anti-MIF antibodies
FR2806095A1 (fr) * 2000-03-10 2001-09-14 Gentech Sequences polynucleotidiques purifiees de plantes et de levure codant pour des proteines qui interagissent avec les produits du genome des geminivirus
WO2001068863A3 (fr) * 2000-03-10 2002-06-20 Gentech S A R L Sequences polynucleotidiques purifiees de plantes et de levure codant pour des proteines qui interagissent avec les produits du genome des geminivirus
KR100602146B1 (ko) 2004-08-31 2006-07-19 학교법인 성균관대학 Ｊａｂ1을 포함하는 바이러스 감염 질환 치료 조성물

Also Published As

Publication number Publication date
BR9815305A (pt) 2001-02-13
AU1380499A (en) 1999-05-31
WO1999024574A3 (fr) 1999-12-09
EP1034274A2 (fr) 2000-09-13

Similar Documents

Publication Publication Date Title
WO1999053072A1 (fr) Homologues de la proteine r1 de phosphorylation de l'amidon
US7605247B1 (en) Nucleic acid molecules encoding a wheat sucrose transporter
EP1097221A2 (fr) Genes codant pour des proteines d'assimilation des sulfates
WO1999047688A1 (fr) Inhibiteurs de proteines d'apoptose dans les plantes
US7189531B2 (en) Nucleic acid encoding plant sugar transport proteins
EP1034274A2 (fr) Homologues vegetaux de pad1 et de crm1 de levure et de jab1 humaine: regulateurs de l'activite du facteur de transcription de type ap-1
US6251668B1 (en) Transcription coactivators
EP1063979A2 (fr) Genes de cycline de cellules vegetales
US6893853B1 (en) Chromatin associated proteins
US7588917B2 (en) Nucleic acids encoding sugar transport proteins and methods of using same
US7332300B2 (en) Plant sugar transport proteins
EP1056863A1 (fr) FACTEUR DE TRANSLATION eIF-4E DE VEGETAUX
EP1076709A2 (fr) Saccharose phosphate synthase
EP1068324A2 (fr) 1,3-beta-d-glucane synthases vegetales et sequences codant brittle-1
US6559354B1 (en) Transcription and gene expression regulators
US7041476B2 (en) Plant sugar transport proteins
US6897356B1 (en) Thioredoxin H homologs
WO2000036121A2 (fr) Proteines phosphatases de plantes
WO2000036110A2 (fr) Genes resistants aux maladies de plantes
US6939710B2 (en) Genes encoding sulfate assimilation proteins
WO1999043827A1 (fr) Cyclopropane-acyle-gras-phospholipide synthase
WO2000036119A2 (fr) Proteines metaboliques du phosphatidylinositol vegetal
WO1999053082A2 (fr) Transporteurs de l'hexose

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GD GE HR HU ID IL IS JP KG KP KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GD GE HR HU ID IL IS JP KG KP KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1998957575

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: 1998957575

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998957575

Country of ref document: EP